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Regulatory T (Treg) and T helper 17 (Th17) cells were
recently proposed to be reciprocally regulated dur-
ing differentiation. To understand the underlying
mechanisms, we utilized a Th17 reporter mouse
with a red fluorescent protein (RFP) sequence in-
serted into the interleukin-17F (IL-17F) gene. Using
IL-17F-RFP together with a Foxp3 reporter, we found
that the development of Th17 and Foxp3+ Treg cells
was associated in immune responses. Although
TGF-b receptor I signaling was required for both
Foxp3 and IL-17 induction, SMAD4was only involved
in Foxp3 upregulation. Foxp3 inhibited Th17 differen-
tiation by antagonizing the function of the transcrip-
tion factors RORgt and RORa. In contrast, IL-6 over-
came this suppressive effect of Foxp3 and, together
with IL-1, induced genetic reprogramming in Foxp3+
Treg cells. STAT3 regulated Foxp3 downregulation,
whereas STAT3, RORg, and RORa were required
for IL-17 expression in Treg cells. Our data demon-
strate molecular antagonism and plasticity of Treg
and Th17 cell programs.
INTRODUCTION
Naive CD4+ helper T (Th) cells, upon encountering their cognate
antigens presented on professional antigen-presenting cells
(APCs), differentiate into effector cells that are characterized
by their cytokine production profiles and immune-regulatory
functions. In addition to Th1 and Th2 cells (Dong and Flavell,
2000), a third subset of effector Th cells, Th17, has been identi-
fied; these produce IL-17, IL-17F, and IL-22 and regulate inflam-
matory responses by tissue cells (Dong, 2008). Th17 cell differ-
entiation in mouse is initiated by TGF-b and IL-6. Recently,
IL-21 was reported as an autocrine factor induced by IL-6 to reg-
ulate Th17 cell differentiation. STAT3, downstream of IL-6 and
IL-21, is essential for RORgt and RORa expression and Th17
cell differentiation (Laurence et al., 2007; Yang et al., 2007).
STAT3 may function by regulating the expression of two orphan44 Immunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc.nuclear receptors, RORgt and RORa, in developing Th17 cells
(Ivanov et al., 2006; Yang et al., 2008b).
Thymus-derived natural regulatory T (nTreg) cells represent
a unique subpopulation of CD4+ T cells that inhibit T cell prolifer-
ation and autoimmune responses (Wing et al., 2006). The hall-
mark of nTreg cells is the expression of Foxp3 transcription fac-
tor, which is required for maintaining Treg cell function (Williams
and Rudensky, 2007). TGF-b has been shown to maintain pe-
ripheral nTreg cells; its deficiency leads to development of early
lethal autoimmunity (Marie et al., 2005; Shull et al., 1992). More-
over, in the presence of TGF-b, Foxp3 can be also induced in
naive T cells in the periphery, and the resulting inducible Treg
(iTreg) cells exhibit a suppressive phenotype similar to that in
nTreg cells (Wing et al., 2006).
As describe above, TGF-b is required for regulation of nTreg
and iTreg cells, and it is also involved in Th17 cell differentiation.
Thus, there is not only functional antagonism between Th17 and
Treg cells in autoimmunity, but also reciprocal regulation in the
generation of these cells. Although TGF-b induces Foxp3 ex-
pression, IL-6 and IL-21 inhibit this regulation and together
with TGF-b drive Th17 cell differentiation. The molecular mecha-
nisms underlying this differential T cell fate decision initiated by
cytokines is unclear. In the present study, we have analyzed
the molecular interaction of Treg and Th17 cell genetic pro-
grams in response to cytokine regulation. To better address
this question, we utilized a Th17 reporter mouse with a red fluo-
rescent protein (RFP) coding sequence inserted into the IL-17F
gene. Our data reveal intrinsic association of Th17 and Treg
cell differentiation programs in activated T cells in vitro and
in vivo. In addition, we have analyzed the genetic programming
and reprogramming of Treg and Th17 cells. The results re-
vealed the molecular antagonism of Treg and Th17 cell genetic
programs and indicated the plasticity of T cell differentiation
programs.
RESULTS
Generation and Characterization of an IL-17F-RFP
Reporter Mouse
To better characterize Th17 cell differentiation, we generated an
IL-17F reporter strain by insertion of a cassette containing an in-
ternal ribosome entry site (IRES)-driven red fluorescent protein
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the IL-17F gene through homologous recombination in murine
embryonic stem cells (Yang et al., 2008a). Heterozygous
IL-17F-RFP (hereafter referred as Il17f rfp) mice were first tested
for the fidelity of RFP expression in reporting Th17 cells. Naive
CD4+CD25CD62LhiCD44lo T cells were isolated from Il17f rfp
mice by fluorescence-activated cell sorting (FACS) and differen-
tiated under Th1, Th2, Th17, and iTreg conditions. Four days af-
ter activation, RFP was highly expressed in Th17 cells but not in
Th1 and Th2 cells (Figure 1A). Notably, under iTreg condition,
weak expression of RFPwas also observed (Figure 1A), although
IL-17 protein was not expressed (data not shown).
Because not all cells differentiated under Th17 cell conditions
express RFP, we next sorted RFP+ and RFP subsets from the
above Th17 culture by flow cytometry and then evaluated IL-17
and IL-17F expression by intracellular staining. In RFP+ popula-
tion, there was a substantial IL-17 and IL-17F double-producing
subset andan IL-17Fsingle expressionsubset (Figure1B). In con-
trast, RFP cells did not express IL-17 or IL-17F.Next,wealsoas-
sessed the gene expression profiles of RFP+ and RFP cells in
Th17 culture by real-time RT-PCR and compared them to Th0
(T cells differentiated under neutral conditions), Th1, Th2, and
iTreg cells. The RFP+ but not RFP population highly expressed
Th17 signature genes, including Il17a, Il17f, Il22, Il21, Il23r, and
Rorc (encoding RORgt), and upregulated Rora (encoding RORa)
gene expression (Figure S1A available online). Th1-, Th2-, and
iTreg-specific genes (Tbx21, Gata3, and Foxp3, respectively)
were not highly expressed in the RFP+ cells (Figure S1A).
Because IL-17F-RFP marks Th17 cells, we further utilized T
cells from Il17f rfp mice to characterize the cytokine regulation
of Th17 cell differentiation. Naive T cells isolated from Il17f rfp
mice were activated in the presence or absence of IL-6, IL-21,
or TGF-b or a combination of the cytokines. Unlike the neutral
condition, IL-6 or TGF-b slightly increased the number of RFP-
expressing cells (Figure 1C); in these cells, IL-17F was ex-
pressed at low amounts (Figure S1B). The combination of
TGF-b with IL-6 or IL-21 greatly increased the frequency of
RFP-expressing cells (Figure 1C). Cytokine staining revealed
that IL-17F expression correlated well with RFP expression
(Figure S1B). IL-17 expression also correlated with RFP expres-
sion under IL-6, TGF-b and IL-6, or TGF-b and IL-21 conditions
but not under TGF-b stimulation (Figure S1B).
Lamina propria was previously shown as a site where some T
cells constitutively express IL-17 (Ivanov et al., 2006). We thus
isolated lamina propria cells from wild-type, Il17f rfp, and Il17f rfp/rfp
mice and examined RFP expression in CD4+ T cells. Although T
cells from wild-type mice had no background fluorescence, ap-
proximately 2% from Il17f rfp and 8% of those from Il17f rfp/rfp
mice expressed RFP (Figure S2A). To further characterize the
RFP+ cells in lamina propria, we sorted RFP+ and RFP fractions
by flow cytometry and performed gene expression analysis by
real-time RT-PCR. The RFP+ population exhibited a Th17 gene
expression profile—they highly expressed IL-17, IL-17F, and
IL-22 as well as upregulated IL-23R, RORa, and RORgt expres-
sion (Figure S2B).
We also utilized the reporter mice to identify IL-17-expressing
cells in vivo. In spleen, in contrast to lamina propria, only a minor
population of CD4+CD25CD62LloCD44hi memory T cells and
a very small percentage of natural killer T (NKT) cells expressedRFP upon restimulation (Figure S2C). Moreover, a substantial
portion of gd T cells was RFP+ (Figure S2C). These results sug-
gest not only that our reporter mice can be used to characterize
various IL-17-expressing T cells, but also that gd T cells may
constitute a major source of IL-17 and IL-17F cytokines in vivo.
To analyze Th17 cells generated under pathological condi-
tions, we immunized Il17f rfp and wild-type mice with myelin oli-
godendrocyte glycoprotein (MOG) peptide emulsified in com-
plete Freund’s adjuvant (CFA). Five days later, splenocytes and
draining lymph node cells were harvested from the immunized
mice and restimulated with MOG peptide for 24 hr. As assessed
by FACS, RFPwas expressed in about 1%–2%of the CD4+ cells
from Il17f rfp mice (Figure 1D), comparable to the frequency of
IL-17- and IL-17F-secreting cells (data not shown). In wild-type
mice, no RFP+ cells were observed.
To understand the characteristics of pathogenic Th17 cells,
we induced experimental autoimmune encephalomyelitis (EAE)
in Il17f rfp and wild-type mice. When most of the mice reached
clinic score 3, with a symptom of hind-leg paralysis, the central
nervous system (CNS) infiltrates were isolated and analyzed for
IL-17F-RFP expression. In the CNS infiltrates from Il17f rfp mice,
approximately 20% of CD4+ cells expressed RFP (Figure 1E). To
further characterize these Th17 cells in the CNS, we sorted RFP+
and RFPCD4+ T cells from the CNS infiltrates of Il17f rfpmice by
FACS and performed gene expression analysis by real-time
RT-PCR. The RFP+ cells from the CNS highly expressed
mRNA for Th17-specific genes Il17a, Il17f, Il22, Il23r, and Rorc
(Figure 1F). RFP cells highly expressed Ifng and Tbx21, corre-
lating with a large population of IFN-g-secreting cells in the CNS
of EAE mice (data not shown). Thus, Il17f rfp reporter sensitively
and faithfully marked Th17 cells in vitro and in vivo.
Analysis of Treg and Th17 Cell Development with
an IL-17F and Foxp3 Dual-Reporter Mouse
To investigate the relationship between Th17 and iTreg during
T cell activation, we crossed Il17f rfp with Foxp3gfp reporter
mice (Fontenot et al., 2005) and produced an Il17f rfpFoxp3gfp
dual reporter. Naive (GFPCD44loCD62Lhi) CD4+ T cells were
activated with anti-CD3 and anti-CD28 in the presence of IL-2
under iTreg (TGF-b, anti-IL-4, and anti-IFN-g) or Th17 (TGF-b
and IL-6) conditions for 1–4 days. IL-17F-RFP versus Foxp3-
GFP expression was assessed daily by FACS. On day 1,
Foxp3 expression was weakly induced in cells activated under
either iTreg or Th17 conditions, and there was no cell expressing
RFP (Figure 2A). On day 2, GFP+ cells were markedly increased
in both conditions, and RFP-expressing cells started to appear
under the Th17 culture condition. Interestingly, under the Th17
condition, approximately one-third of Foxp3-GFP+ cells also ex-
press RFP (Figure 2A), indicating that iTreg and Th17 cell differ-
entiation can be simultaneously induced, at least in a portion of
the activated T cells. On days 3 and 4, GFP+ cell numbers
were drastically reduced, whereas percentage of RFP+GFP
cells was greatly increased. The presence of exogenous IL-2
did not affect the kinetics of RFP and GFP expression
(Figure S3A). Moreover, on days 2 and 3, GFP+ cells did not ex-
hibit increased apoptosis as examined by Annexin V staining
(Figure S3B), suggesting that the Foxp3-GFP+ cells on day 2 in
this culture did not preferentially undergo cell death. Compared
with the Th17 condition, under the iTreg condition, althoughImmunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc. 45
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Interplays of Treg and Th17 ProgramsFigure 1. IL-17F-RFP Reporter Is Highly Expressed in Th17 Cells Generated In Vitro and In Vivo
(A) FACS-sorted naive CD4+CD25CD62LhiCD44lo T cells from Il17f rfpmice were activated under the Th1, Th2, Th17, and inducible regulatory T cell (iTreg) con-
ditions with plate-bound anti-CD3 and anti-CD28 for 4–5 days, and RFP (IL-17F) expression was analyzed by FACS.
(B) RFP+ and RFP cells from above Th17 culture were sorted by FACS and rested for 24 hr. The cells were then restimulated by PMA and Ionomycin for 5 hr, and
IL-17- and IL-17F-expressing cells were assessed by intracellular staining. Data shown represent at least three independent experiments.
(C) Naive T cells from Il17f rfpmice were activated in the presence of the indicated cytokine stimuli for 3–5 days. The cells were then analyzed for RFP expression
by FACS. Data shown were repeated twice with consistent results. Numbers represent the percentage of RFP+ cells.
(D–F) IL-17F-RFP reporter expression in Th17 cells generated in EAE. (D) Il17f rfp andWTmice were immunized byMOG and CFA for 5 days, and RFP expression
was analyzed by FACS after ex vivo recalled byMOGpeptide. Data shownwere on aCD4+ gate. (E) IL-17F-RFP expression in CD4+ T cells fromCNS of EAEmice.
EAE was induced in Il17f rfp andWTmice and infiltrates from the CNS of the EAEmice were isolated at the clinic score 3. IL-17F-RFP expression was analyzed by
FACS in a CD4+ gate. Data shown represent at least three mice from each group with consistent results. (F) RFP+ and RFP CD4+ cells were sorted from CNS of
Il17f rfp EAE mice, and the gene expression profile was analyzed by real-time RT-PCR. Data were normalized to a reference gene, Actb. The lower expression for
each gene was referred as 1. The graph shows means ± standard deviation (SD).IL-17 expression was not detected (data not shown), weak RFP
expression was found on day 2 and more substantially on day 3
in both GFP+ and GFP populations but it was greatly reduced
on day 4 (Figure 2A). For further analysis of the RFP+GFP+ cells
associated with iTreg cell differentiation, GFP+RFP and
GFP+RFP+ cells were sorted on day 3 from the iTreg culture
and examined by real-time RT-PCR for their gene expression.
RFP+ cells expressed similar amounts of Foxp3 as RFP cells
but markedly upregulated expression of Th17-specific genes
IL-17, IL-17F, RORgt, and RORa (Figure 2B), supporting a dual
program in these cells. These results indicate that under both
Th17 and Treg cell conditions, Foxp3 and IL-17F coexpressors
were induced transiently in some T cells before they were termi-
nally differentiated into single producers, supporting the intimate
relationship of Treg and Th17 cells during their development.
We then asked whether this RFP+GFP+ population or state
also exists in the immune response in vivo. In naive Il17f rfp-
Foxp3gfp mice, splenic and laminal propria CD4+ T cells con-
tained RFP and GFP single-positive cells; very few, if any, dou-46 Immunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc.ble-positive cells were observed (Figure 2C). For analysis of
the regulation of T cell differentiation in immune responses,
Il17f rfpFoxp3gfp dual-reporter and wild-type mice were immu-
nized with MOG in CFA, and IL-17F-RFP and Foxp3-GFP were
detected by FACS after MOG ex vivo restimulation. In compari-
son to CD4+ T cells fromwild-typemice, about 1%of RFP+GFP
Th17 cells and 4% of GFP+RFP Treg cells were observed in the
dual-reporter mice after the immunization (Figure 2C). A small
but detectable percentage (less than 0.1% of total CD4+ T cells
and approximately 7%–8% of RFP+ cells) of T cells expressed
both RFP and GFP (Figure 2C), suggesting that Th17 and Treg
cells generated in vivo also share intrinsic common programs
with those differentiated in vitro.
TGF-b Signaling Requirements during Th17 and iTreg
Cell Differentiation
TGF-b regulates iTreg and, together with IL-6, Th17 cell differen-
tiation, but the underlying signaling mechanism is unclear. For
analysis of this, naive cells from C57BL/6 (B6) mice were
Immunity
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TGFbRI kinase activity, SB431542, was added at different time
points during the Th17 cell differentiation. Inhibition of TGF-b sig-
naling on day 0 or day 1 completely abolished IL-17 production
(Figure 3A). Moreover, a 50% reduction in IL-17 production was
observed after addition of the inhibitor on day 2, whereas no sub-
stantial inhibition was found on day 3 (Figure 3A). Real-time
RT-PCR analysis also indicated decreased expression of IL-17,
IL-17F, RORa, RORgt, and IL-23R mRNA in Th cells after addi-
tion of SB431542 on days 0 and 1 (Figure 3B). Similar to Th17
cell differentiation, TGF-b signaling was also required during
the first 2 days after initiation of iTreg cell differentiation
(Figure 3C). These data indicate that active TGF-b signaling is re-
quired during the first 2 days of Th17 and Treg cell differentiation.
TGF-b receptor activation induces activation and phosphory-
lation of Smad2 and Smad3, which then bind to Smad4 and
translocate to the nucleus (Feng and Derynck, 2005). Therefore,
we next investigated the role of Smad4 by using Smad4-defi-
cient CD4+ T cells. Mice with Smad4 deletion in T cells were gen-
erated by breeding mice with floxed Smad4 (fl) alleles (Chu et al.,
2004) with CD4-Cre mice (Lee et al., 2001). Deletion of the
Smad4 gene in CD4+ T cells from Smad4fl/flCD4Cre+ mice was
confirmed by PCR (Figure S4A). Smad4fl/flCD4Cre+ mice exhibit
normal populations of CD4+ and CD8+ T cells, as well as nTreg
cells in spleen, lymph nodes, and thymus (Figures S4B and
S4C). Moreover, Smad4-deficient nTreg were as suppressive
as wild-type nTreg (Figure 3D). The proliferation of naive CD4+
T cells from wild-type or Smad4fl/flCD4Cre+ mice was inhibited
by nTreg from either wild-type or Smad4fl/flCD4Cre+ mice
(Figure 3D). Thus, Smad4 is not required for nTreg cell develop-
ment and suppressive activity or naive T cell suppression by
nTreg cells. We next investigated whether Smad4 is required
for iTreg or Th17 cell differentiation by stimulating naive Th cells
under iTreg or Th17 conditions. Smad4-deficient Th cells
showed reduced Foxp3 expression compared to wild-type T
cells upon iTreg induction (Figure 3E). However, upon Th17
cell differentiation, comparable numbers of IL-17-producing
cells were observed between Smad4-deficient and wild-type T
cells (Figure 3F), indicating that Smad4 is differentially required
for iTreg and Th17 cell differentiation. Further in vivo analysis
showed no difference in IL-17, IL-17F, and IL-22 production be-
tween wild-type and Smad-4 deficient T cells after KLH immu-
nization (Figure S4D). Thus, although active TGF-b signaling
regulates both iTreg and Th17 cell differentiation, different
downstream molecules may be utilized to regulate the develop-
ment of these two T cell lineages.
Regulation of Th17 Cell Differentiation by Foxp3
Because TGF-b induces the expression of Foxp3, we next as-
sessed Foxp3 function in Th17 cell differentiation. First, we over-
expressed Foxp3 in T cells by retroviral transduction. Naive
CD4+ T cells from OT-II mice were activated with Ova peptide
and irradiated splenic APCs under Th17 conditions. On day 1,
activated T cells were infected with bicistronic retroviruses con-
taining an IRES-GFP. Four days after infection, IL-17- and
Foxp3-expressing cells were determined by intracellular stain-
ing. Compared to cells infected with a control virus, Foxp3 over-
expression greatly decreased the percentage of IL-17-secreting
cells (Figure 4A). We then sorted GFP and GFP+ cells from the
above experiment, and their gene expression profiles were as-
sessed with real-time RT-PCR. In comparison with cells infected
with the control virus, Foxp3 overexpression greatly reduced
IL-17, IL-17F, and IL-21 mRNA expression, whereas RORgt
and RORa expression remained the same (Figure 4B). These
Figure 2. Reciprocal Th17 and iTreg Cell
Differentiation
(A) Naive T cells from Il17f rfpFoxp3gfp mice were
activated in the presence of IL-2 under iTreg
(TGF-b, anti-IL-4, and anti-IFN-g) or Th17 (TGF-b
and IL-6) cell conditions for 1–4 days. IL-17F-RFP
and Foxp3-GFP expression was assessed daily by
FACS. Data shown were repeated twice with con-
sistent results.
(B) On day3, RFP+ and RFP subsets were sorted
on a GFP+ gate from the iTreg cell culture, and
gene expression was assessed by real-time RT-
PCR. Data shown were normalized to expression
of a reference gene, Actb. The lower expression
for each gene was referred as 1. The graph shows
means ± SD.
(C) Magnetic activated cell sorting (MACS)-en-
riched splenic (SP) and laminal propria (LP) CD4+
cells from unmanipulated (No, no immunization)
Il17f rfpFoxp3gfp mice were restimulated with anti-
CD3 and IL-23 for 24 hr, and expression of RFP
and GFP was analyzed by flow cytometry. In addi-
tion, CD4 cells were enriched by MACS from
spleen and draining lymph nodes of the MOG
and CFA immunized wild-type (WT) or Il17f rfp/
Foxp3gfp mice, and RFP and GFP expression
was assessed by FACS after MOG restimulation.
In (A) and (C), numbers in each quadrant represent
the percentage of cells.Immunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc. 47
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FACS-sorted naive T cells from B6mice were activated under (A and B) Th17 (TGF-b, IL-6, IL-23, anti-IFN-g, and anti-IL-4) or (C) iTreg cell conditions, and a TGF-
bRI kinase inhibitor (SB431542, 5 mM) was added at different time points as indicated. Cells were assessed for IL-17 and IFN-g production and Foxp3 expression
after 4 days of stimulation by intracellular staining.
(A and C) A representative dot-plot graph is shown in the left panel, and the numbers in quadrants represent the percentages. In the right panel, the percentage of
(A) IL-17+ or (C) Foxp3+ cells for six independent experiments is indicated. *, p < 0.05, Wilcoxon signed-rank test.
(B) mRNA expression of indicated geneswas analyzed by real-time RT-PCR. The data shownwas normalized to expression of a reference gene,Actb. The lowest
expression for each gene was referred as 1.
(D) Naive T cells from Smad4fl/flCD4-Cre (WT) or Smad4fl/flCD4-Cre+ (Smad4/) mice were cultured with or without WT or Smad4/CD4+CD25+ nTreg cells in
triplicate wells with irradiated APCs and stimulated with 2 mg/ml of anti-CD3. Proliferation was assayed 72 hr after treatment by addition of [3H]-thymidine to the
culture for the last 8 hr. A representative example of three independent experiments is shown.
In (A)–(F), the graphs show means ± SD.
(E and F) Naive Smad4-sufficient or -deficient T cells were activated under (E) iTreg or (F) Th17 cell conditions, and IL-17, IFN-g, and Foxp3 expression was
analyzed by intracellular staining. Numbers in quadrants represent the percentages. The experiments were repeated three times with consistent results.results indicate that Foxp3 inhibits Th17 cell differentiation and
suggest that it might not inhibit RORa or RORg mRNA expres-
sion but rather interfere with their function.
For analysis of the regulation of RORa and RORgt function by
Foxp3, EL-4 cells were transfected with an Il17a-promoter-
CNS2 luciferase reporter vector (Yang et al., 2008b) in the pres-
ence or absence of RORa or RORgt with or without Foxp3-
expressing vector. Whereas RORa or RORgt alone induced
luciferase activity, coexpression of Foxp3 markedly reduced
their activity (Figures 4C–4F and Figures S5D–S5F). Because
neither the IL-17 promoter nor the CNS2 element contains a de-
tectable Foxp3-binding site, we analyzed whether Foxp3 DNA48 Immunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc.binding or homodimerization is required for its ability to suppress
RORa or RORgt function. Foxp3DFKH, a Foxp3 mutant lacking
the forkhead domain but with the SV40 nuclear localization se-
quence (Lee et al., 2008), or Foxp3DE250, a Foxp3 mutant that
possesses a single amino acid deletion in the leucine-zipper do-
main and thus cannot homodimerize or bind to DNA well (Chae
et al., 2006), was coexpressed with RORgt. These two mutants
were found to still inhibit RORgt-driven luciferase activity
(Figure 4C). Foxp3DE250 and Foxp3DFKH also inhibited Th17
cell differentiation in primary T cells (data not shown). Further-
more, Foxp3 also directly inhibited RORg activation of a RORE
reporter in a dose-dependent manner (data not shown). Our
Immunity
Interplays of Treg and Th17 ProgramsFigure 4. Foxp3 Inhibits Th17 Cell Cytokine Induction by Antagonizing RORgt Function
(A) FACS-sorted naive OT-II T cells were activated under Th17 conditions and infected with an IRES-GFP-containing bicistronic retrovirus expressing Foxp3 or
a vector control virus. IL-17- and Foxp3-expressing cells were measured by intracellular staining on the GFP and GFP+ population. The experiments were
repeated at least three times with similar results.
(B) GFP and GFP+ cells were sorted from (A) and restimulated for 4 hr with anti-CD3. mRNA expression of indicated genes was analyzed by real-time RT-PCR.
The data shown were normalized to expression of a reference gene, Actb. The lowest expression for each gene was referred as 1. *, p < 0.05, t test.
(C–F) EL-4 cells were transfected with a vector containing the firefly luciferase gene under the control of the Il17a promoter-CNS2 region, a vector expressing
Renilla luciferase, and IRES-GFP-containing bicistronic vectors expressing RORgt, Foxp3 wild-type (WT), or various Foxp3 mutants, or vector alone. Luciferase
activity was determined and normalized to Renilla luciferase. Values were also normalized to vector alone. The data represent at least four independent exper-
iments with consistent results. *, p < 0.05, t test.
In (B)–(F), the graphs show means ± SD.
(G) Naive OT-II T cells were activated under Th17 conditions and infected with indicated viruses. IL-17 expression was analyzed by intracellular staining on either
GFP+ or GFP gate.
(H) Naive WT or Scurfy OT-II T cells were stimulated with the indicated cytokines and neutralizing antibodies. Four days later, cells were assessed for IFN-g and
IL-17 production by intracellular staining. The data represent at least three independent experiments with consistent results.data together indicate that Foxp3 overexpression inhibits
RORgt activity independently of Foxp3 homodimerization or
DNA binding.
Nuclear receptors bind to coactivators or corepressors
through interaction between the AF2 domains of the nuclear re-
ceptors with LxxLLmotifs in coactivators and/or corepresors. To
understand how Foxp3 inhibits ROR function, we utilized amam-
malian two-hybrid system, in which luciferase reporter activity isactivated upon binding of RORg to an LxxLL-containing peptide
EBIP96 derived from SRC-1 coactivator (Kurebayashi et al.,
2004). Interestingly, Foxp3 inhibited, in a dose-dependent man-
ner, the binding of RORg to the LxxLL-containing peptide
(Figure S5A), indicating that Foxp3may interfere with the associ-
ation of RORgwith its coactivator. Given that Foxp3 contains an
LQALL sequence in its second coding exon, we hypothesized
that Foxp3 might interact with both RORa and RORgt andImmunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc. 49
Immunity
Interplays of Treg and Th17 Programscompete with coactivators for ROR binding. We therefore exam-
ined the interaction of RORa with wild-type Foxp3 and sev-
eral Foxp3 mutants by using coimmunoprecipitation. Although
Foxp3 and RORawere found to associate when they were coex-
pressed in 293T cells, a Foxp3 mutant carrying a mutation in an
LQALL motif (LL-AA mutant) exhibited a greatly decreased
association with RORa (Figure S5B). In addition, a mutant
Foxp3 containing only amino acids encoded by exons 1 and 2,
which include the LQALL motif but no DNA binding or dimeriza-
tion domain, inhibited RORg transcriptional activity (Figure S5C),
suggesting that LQALL in Foxp3 may inhibit RORa or RORg
interaction with a coactivator.
We further tested the function of Foxp3 LQALL motif by use of
the LL-AA mutant. In the mammalian two-hybrid system, the
Foxp3 LL-AA mutant had reduced ability to inhibit the binding of
RORg to EBIP96, compared to Foxp3 wild-type (Figure S5A). To
evaluate the functional implication of this decreased inhibitory
activity by the Foxp3 LL-AA mutant, we analyzed whether lack
of the LxxLL domain impairs Foxp3 ability to inhibit activation
of IL-17 transcription by RORs. We observed a non-statistically
significant dose-dependent downregulation of luciferase activity
by Foxp3 LL-AAmutant when coexpressed with RORgt or RORa
(Figure 4D and Figure S5D). Thus, these results indicate that the
Foxp3 LxxLL domain is important for binding to RORs, but lack
of this domain inhibits but does not completely abolish Foxp3-
mediated interference of ROR activity.
Foxp3 has been previously shown to bind to TIP60 and
HDAC7 (Li et al., 2007). To further explore which additional do-
main of Foxp3 might be required for its inhibitory activity on
RORs, we utilized a Foxp3 D105-190 mutant that does not
bind to TIP60-HDAC7 complex (Li et al., 2007). Interestingly, al-
though this mutant binds to RORa well when they were coex-
pressed in 293T cells (Figure S5B), the ability of Foxp3 to inhibit
transcriptional activity of RORgt was partially reversed by lack
of TIP60-HDAC7-binding domain (Figure 4E and Figure S5E).
Moreover, lack of both LxxLL and TIP60-HDAC7 domains com-
pletely impaired Foxp3 inhibition of RORgt or RORa transcrip-
tional activity (Figure 4F and Figure S5F). For further demonstra-
tion of the role of these domains in inhibition of Th17 cell
differentiation, naive OT-II cells were infected with Foxp3 con-
structs under Th17-polarizing conditions, and IL-17 production
was evaluated by intracellular staining. Overexpression of wild-
type, LL-AA, or D105-190 Foxp3 mutants greatly decreased
the percentage of IL-17-secreting cells compared to cells in-
fected with vector alone (Figure 4G). However, Foxp3 lacking
both the LxxLL and TIP60-HDAC7 domains was not able to in-
hibit IL-17 production (Figure 4G), further demonstrating that
Foxp3 inhibits the activity of RORa and RORg by direct binding
with its LQALL domain and/or by recruiting the TIP60-HDAC7
complex.
To further assess the function of Foxp3 in Th17 cell differenti-
ation, we bred OT-II T cell receptor (TCR) transgenic mice with
Scurfy mice, which have a point mutation in Foxp3 gene. Naive
CD4+ T cells fromwild-type or Scurfy OT-II mice were stimulated
with Ova peptide and irradiated splenic APCs in the presence of
different cytokine stimuli. Similar to wild-type T cells, Scurfy OT-II
cells did not produce IL-17 in the present of TGF-b alone (Fig-
ure 4H, Figure S6A), indicating that Foxp3 deficiency was not
sufficient to convert iTreg into Th17 cells and suggesting that50 Immunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc.IL-6 signaling is required for Th17 cell differentiation and does
not just function by suppressing Foxp3 expression. When they
were activated in the presence of TGF-b and IL-6, reduced pro-
duction of IL-17 and IL-17F and enhanced IFN-g was observed
in the Scurfy T cells (Figure 4H, Figure S6A). However, addition
of blocking antibodies to IFN-g and IL-4 together with TGF-b and
IL-6 resulted in comparable amounts of IL-17 and IL-17F pro-
duction in wild-type and Scurfy Th cells (Figure 4H,
Figure S6A). Real-time PCR analysis also indicated decreased
expression of IL-17, IL-17F, and RORgt mRNA in Scurfy-defi-
cient Th cells compared to wild-type counterparts when they
were activated by TGF-b and IL-6, whereas blocking antibodies
to IL-4 and IFN-g restored their IL-17, IL-17F, and RORgt mRNA
expression (Figure S6B). Taken together, these results indicate
that lack of Foxp3 expression in T cells leads to increased Th1
cell differentiation and does not enhance Th17 cell differentia-
tion. The latter is probably due to an inhibitory effect by IL-6 on
Foxp3 expression and function during Th17 cell differentiation.
Conversion of iTreg to Th17 Cells
Because TGF-b induces Foxp3 on its own whereas IL-6 over-
rides this differentiation process and skews T cells toward
Th17 lineage, we next analyze whether IL-6 is able to inhibit pre-
committed Foxp3-mediated Treg programs. Naive CD4+ T cells
from Foxp3-GFP reporter mice were activated together with
TGF-b, IL-2, and neutralizing antibodies against IL-4 and IFN-g
for 5 days, and Foxp3-GFP+ cells were sorted and restimulated
with various cytokines for 4 days. Foxp3-GFP and IL-17 expres-
sion was determined by flow cytometry. Although iTreg cells
quickly lost Foxp3 expression in the presence or absence of
IL-2 as previously reported (Selvaraj and Geiger, 2007), IL-6
stimulation alone, or in combination with IL-1 and IL-23, en-
hanced Foxp3 downregulation but only slightly increased IL-17
production (Figure 5A). However, when we stimulated iTreg cells
with TGF-b, Foxp3 expression was sustained (Figure 5A). In the
presence of TGF-b, IL-6 alone or in combination with IL-1 and
IL-23 markedly downregulated Foxp3 expression and increased
IL-17 production (Figure 5A). Real-time RT-PCR analysis of other
Th17-specific genes demonstrated substantially enhanced ex-
pression of IL-22, IL-23R, and RORgt mRNA in iTreg cells stim-
ulated with IL-6, IL-1, and IL-23 (Figure 5B). However, the ex-
pression of these genes was not significantly increased in the
presence of TGF-b (Figure 5B). Thus, these results indicate
that the Treg program is turned off by IL-6 and that iTreg cells
can be reprogrammed to Th17 cells in the presence of TGF-b
and IL-6.
Recently, all-trans retinoic acid (RA) was shown to inhibit the
induction of proinflammatory Th17 cells but to promote anti-in-
flammatory Treg cell differentiation (Mucida et al., 2007). We
thus asked whether RA affects redifferentiation of Treg cells
toward Th17 cells. Naive CD4+ T cells from Il17f rfpFoxp3gfp
mice were activated with TGF-b and IL-2 in the presence or ab-
sence of RA. As reported, inclusion of RA enhanced Foxp3 in-
duction (data not shown). Three days later, GFP+RFP cells
were sorted and restimulated in the presence of TGF-b, IL-6,
IL-1, and IL-23. Although pretreatment with RA did not affect
Foxp3 downregulation, it prevented the upregulation of RFP
(IL-17F) and IL-17 expression (Figure 5C). Thus, although iTreg
cells developed in the presence of RA were still susceptible to
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Th17 program.
Cytokine-Driven Conversion of nTreg
Cells into Th17 Cells
Because iTreg cells, even 5 days after differentiation, can be re-
programmed to Th17 cells, we asked whether nTreg cells could
be converted. FACS-sorted CD4+CD25+ T cells from B6 mice,
which contained more than 99% Foxp3-expressing T cells
(data not shown), were activated with plate-bound anti-CD3
and anti-CD28 in the presence of IL-6 for 4 days. Addition of
IL-6 to nTreg cells resulted in expression of IL-17 and downregu-
lation of Foxp3 expression (Figure 6A). Similarly, when nTreg
cells from the IL-17F-RFP reporter mice, which did not express
RFP after sorting (data not shown), were cultured as above,
RFP was induced (Figure 6B). This finding indicates that IL-17F
was also induced by IL-6 in nTreg cells. Next, for determination
of whether IL-17-IL-17F-expressing T cells were suppressive,
RFP+ and RFP cells (Figure 6B) were FACS sorted and sub-
jected to a suppression assay. Similar to nonmanipulated nTreg
cells, RFP cells inhibited the proliferation of naive T cells
(Figure 6C). However, IL-17F-RFP+ cells exhibited greatly re-
duced suppressive activity.
The above experiments suggest that nTreg cells can be re-
programmed and redifferentiated into Th17 cells. To understand
whether such a regulation exists in vivo, we purified CD4+GFP+
Treg cells from Foxp3 reporter mice (CD45.2+) and mixed them
at 1:10 ratios with CD4+CD25 cells from CD45.1+ congenic
mice before transferring them into Rag1/ recipients. More
than 99%of sorted GFP+ cells were stained by an anti-Foxp3 an-
tibody (Figure 6D). Because some nTreg cells are reactive with
MOG peptides (Korn et al., 2007), the recipients were immunized
with MOG peptide in CFA. Five days later, CD45.1+ and CD45.2+
CD4+ T cells were analyzed for Foxp3 and IL-17 expression after
restimulation with PMA plus ionomycin or MOG peptide. As ex-
pected, substantially IL-17 expression was detected in CD45.1+
cells, indicating that the immunization protocol was successful
(Figure 6D). However, in CD45.2+ populations, there was signif-
icant downregulation of Foxp3 expression (Figure 6D). In
addition, IL-17 expression was detected in Foxp3 cells
(Figure 6D). When cells were restimulated with PMA plus iono-
mycin, Foxp3 and IL-17 dual expressers were also observed
(Figure 6D). This result indicates that in the presence of inflam-
matory signals, nTreg cells can differentiate into Th17 cells
in vivo.
Regulation of nTreg Conversion to Th17 Cells
We further examined the regulation of Treg cell differentiation
into Th17 cells by other cytokines by using Treg cells purified
from Foxp3-GFP reporter mice. In addition to IL-6, IL-21 exerted
similar regulation but was less potent (Figure 7A). IL-1 alone in-
duced a small percentage of IL-17-producing cells but did not
Figure 5. Generation of IL-17-Producing
Cells from Inducible Regulatory T Cells
(A and B) FACS-sorted CD4+Foxp3-GFPCD44lo
T cells from Foxp3-GFP mice were stimulated un-
der iTreg-polarizing conditions (TGF-b, IL-2, anti-
IFN-g, and anti-IL-4) for 5 days. Foxp3-GFP+ cells
were FACS sorted and stimulated with plate-
bound anti-CD3 and anti-CD28 in the presence
of the indicated cytokines. (A) Four days later,
IL-17 and Foxp3-GFP expression was determined
by flow cytometry, and (B) mRNA expression of in-
dicated genes was analyzed by real-time RT-PCR.
Numbers in FACS quadrants represent the per-
centages. The data shown in (B) were normalized
to expression of a reference gene,Actb. The graph
shows means ± SD. The lowest expression for
each gene was referred as 1. The data represent
at least three independent experiments with con-
sistent results.
(C) Naive T cells from Il17frft/Foxp3gfp mice were
stimulated with plate-bound anti-CD3, anti-
CD28, TGF-b, IL-2 in the presence or absence of
all-trans retinoic acid (RA). Three days later,
Foxp3-GFP+IL-17F-RFP cells were sorted and
cultured with plate-bound anti-CD3 and anti-
CD28 in the presence of TGF-b, IL-1, IL-6, and
IL-23. Four days later, IL-17, IL-17F-RFP, and
Foxp3-GFP expression was determined by flow
cytometry. Numbers in FACS quadrants represent
the percentages. The data represent at least two
independent experiments with consistent results.Immunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc. 51
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(A) FACS-sorted CD4+CD25+ T cells from B6 mice were stimulated with plate-bound anti-CD3 and anti-CD28 in the presence of indicated cytokines. Four days
later, cells were assessed for IL-17 and Foxp3 expression by intracellular staining.
(B) FACS-sorted CD4+CD25+ T cells from IL-17F-RFP reporter mice were activated with anti-CD3, anti-CD28, and IL-6 for 4 days. RFP expression was analyzed
by flow cytometry.
(C) RFP+ and RFP cells were sorted from (B) for suppression assays. Naive T cells from B6 mice were cultured in triplicate wells with or without CD4+CD25+
T cells from B6 mice or the sorted RFP+ or RFP cells in the presence of irradiated APCs and 2 mg/ml anti-CD3. Proliferation was assayed 72 hr later by adding
[3H]-thymidine to the culture for the last 8 hr. The graph shows means ± SD. The data represent at least two independent experiments with consistent results.
(D) CD4+GFP+ cells from Foxp3-GFP reporter mice (CD45.2+) and CD4+CD25CD62LhiCD44lo cells (CD45.1+) fromB6.SJL congenicmice were FACS sorted and
mixed at 1:10 ratio before being intravenously transferred into Rag1/ syngenic mice (5 3 106 cells/mouse, n = 3). The recipient mice were immunized subcu-
taneously with 150 mg of MOG35–55 peptide emulsified in CFA. Five days later, lymphoid cells from spleens were isolated and restimulated with MOG or PMA and
Ionomycin before IL-17 and Foxp3-GFP expression was determined by flow cytometry for each individual mouse. A representative result is shown.markedly change the expression of Foxp3. However, in the pres-
ence of IL-6 or IL-21, IL-1 further enhanced the percentages of
IL-17-positive cells, without any additional impact on Foxp3 ex-
pression (Figure 7A). No synergistic effect by IL-23was observed
(Figure 7A). Because nTreg cells produce TGF-b, we next exam-
ined whether TGF-b was required for the IL-6-mediated conver-
sion of nTreg to Th17 cells. Addition of a blocking antibody to
TGF-b abolished IL-17 expression induced with IL-6, IL-1, and
IL-23 but did not enhance Foxp3 expression (Figure 7A). Thus,
although TGF-b, IL-6, IL-21, and IL-1 regulate the induction of
IL-17-producing cells, IL-6 seems most potent and unique in
downregulating Foxp3 expression.
nTreg cells from mesenteric lymph nodes could be also con-
verted into Th17 cells upon activation in the presence of IL-6,
IL-1, and IL-23 (Figure S7A). To rule out the possibility that the
converted cells were iTreg generated in the periphery, we iso-
lated CD4+CD8 GFP+ thymocytes from Foxp3-GFP reporter
mice and subjected them to conversion by IL-6, IL-1, and
IL-23. Similar to their peripheral counterparts, thymic Treg cells
downregulated Foxp3 and expressed IL-17 upon treatment
with IL-6, IL-1, and IL-23 (Figure S7B). Thus, nTreg cells are de-
velopmentally programmed to respond to inflammatory cyto-
kines and undergo redifferentiation into Th17 cells.
To better characterize the conversion of nTreg cells to Th17
cells, we utilized Treg cells from Il17f rfpFoxp3gfp double-reporter52 Immunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc.mice. FACS-sorted CD4+GFP+ cells from these mice were acti-
vated with plate-bound anti-CD3 and anti-CD28 in the presence
of IL-6, IL-1, and IL-23. Downregulation of Foxp3 expression was
detected on day 1 and was further enhanced during the next
3 days (Figure 7B). RFP expression was observed on day 2
and optimally induced on days 3 and 4. Interestingly, similar
numbers of IL-17F single-positive and IL-17F+Foxp3+ cells
were observed on days 2 and 3; however, on day 4, the majority
of IL-17F-producing cells did not express Foxp3-GFP
(Figure 7B). For further characterization of these populations,
IL-17F and Foxp3 single-positive cells were FACS sorted, and
the expression of Th17 and Treg lineage-specific genes were an-
alyzed by real-time RT-PCR. IL-17F-RFP single-positive cells
expressed higher amounts of IL-17, IL-17F, IL-21, IL-23R, and
RORgt mRNA than did Foxp3-GFP single-positive cells
(Figure S8). Interestingly, Foxp3-GFP+ cells also upregulated
RORgt, although they did not express Th17 markers, suggesting
that Foxp3 repressed the function of RORgt in these cells. Thus,
this result indicates that converted IL-17F-producing cells have
the same phenotype as Th17 cells.
To determine whether STAT3, RORgt, and RORa are required
for conversion of nTreg cells into Th17 cells, we first bredSTATfl/fl
mice with CD4-Cre mice, and we observed efficient deletion of
STAT3 in T cells (data not shown). FACS-sorted CD4+CD25+
T cells from STAT3- and RORg-deficient (Kurebayashi et al.,
Immunity
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(A) FACS-sorted CD4+Foxp3-GFP+ T cells from Foxp3-GFP reporter mice were stimulated with plate-bound anti-CD3 and anti-CD-28 in the presence of the
indicated cytokines with or without anti-TGF-b (10 mg/ml) for 4 days. Cells were analyzed for IL-17 and GFP expression.
(B) CD4+Foxp3-GFP+ T cells from Il17f rfp-Foxp3gfp mice were stimulated in the presence of IL-6, IL-1, and IL-23 for the indicated days, and IL-17F-RFP and
Foxp3-GFP expression was determined by flow cytometry.
(C–E) CD4+CD25+ T cells from wild-type (WT) and (C) Stat3-, (D) RORg-, or RORg/a- or (E) IL-21-deficient mice were stimulated in the presence of indicated
cytokines. Four days later, cells were assessed for Foxp3 and IL-17 expression by intracellular staining. Numbers in quadrants represent the percentages.
The data represent at least three independent experiments with consistent results.2000) mice (the latter is deficient in all RORg isoforms including
RORgt) and from Rorasg/sg and Rorasg/sgRorc/ mice (Yang
et al., 2008b) and their appropriate controls were stimulated
with plate-bound anti-CD3 and anti-CD28 in the presence of var-
ious cytokines, and Foxp3 and IL-17 expression were deter-
mined by intracellular staining. STAT3-deficient nTreg cells failed
to downregulate Foxp3 expression or express IL-17 (Figure 7C).
In contrast, Rorc/ nTreg cells downregulated Foxp3 expres-
sion but only expressed very low amounts of IL-17 when com-
pared to their controls (Figure 7D). Compared to RORg defi-
ciency, RORa mutant T cells exhibited moderate reduction in
IL-17 expression but normal Foxp3 downregulation (Figure S9).
T cells defective in both RORa and RORg were also able to
downregulate Foxp3 but had complete IL-17 deficiency
(Figure 7D). Thus, these data indicate that although STAT3,
RORg, and RORa are all required for IL-17 expression, Foxp3downregulation is regulated by STAT3, but not by RORg or
RORa.
Because IL-17F-RFP+Foxp3-GFP cells expressed IL-21
(Figure S8), we investigated whether this cytokine is required
for Th17 induction in nTreg cells. FACS-sorted CD4+CD25+ T
cells from IL-21-deficient mice and their appropriate controls
were stimulated in the presence of various cytokines. IL-21-de-
ficient nTreg cells exhibited normal downregulation of Foxp3
and conversion into IL-17-producing cells (Figure 7E), indicating
that autocrine IL-21 is not required for IL-6-mediated conversion
of nTreg cells.
DISCUSSION
In this study, we have investigated the molecular interactions of
the Treg and Th17 genetic programs (Figure S10). Using anImmunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc. 53
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found the presence of a RFP+GFP+ transient phase upon T cell
activation in vitro and in vivo, indicating that both Th17 and
Treg cell programs could be simultaneously induced in some
T cells before they are terminally differentiated into either lineage.
On the one hand, Foxp3, induced by TGF-b via SMAD4, inhibits
Th17 cell differentiation by antagonizing RORgt and RORa activ-
ity. On the other hand, IL-6 induces Foxp3 downregulation in
Treg cells and, together with IL-1 and TGF-b, reprograms them
to become Th17 cells. In nTreg, this process is mediated by
STAT3, RORa, and RORgt.
TGF-b plays an important role in the development, mainte-
nance, and induction of regulatory T cells. Ourmutagenesis anal-
ysis reveals that Foxp3 could compete with coactivator binding
to RORs via two independent and nonexclusive mechanisms.
Moreover, we found that Scurfy T cells, compared to their
wild-type counterparts, exhibited reduced expression of Th17
cytokines and RORa and RORgt when stimulated with TGF-b and
IL-6; this reduced expression was associated with increased
Th1 cell differentiation. However, when IFN-g and IL-4 were
blocked under the same conditions, restoration of Th17
cytokines and RORgt was observed. Therefore, lack of Foxp3
expression in T cells results in enhanced Th1 cell differentiation,
but Foxp3, although transiently induced in some T cells undergo-
ing Th17 development, is not required for Th17 cell lineage differ-
entiation. Furthermore, because Scurfy T cells did not spontane-
ously develope into Th17 cells in the presence of TGF-b, it
suggests that TGF-b signaling is not sufficient to drive Th17
cell differentiation. STAT3 downstream of IL-6 may be also re-
quired, which does not merely function by downregulating
Foxp3. Our results thus further support the synergy of TGF-b and
IL-6 in Th17 cell differentiation.
IL-6 inhibits TGF-b-dependent Foxp3+ Treg cell induction
(Bettelli et al., 2006). Our current study also indicates that IL-6
can reprogram fully differentiated iTreg and nTreg cells and redif-
ferentiate them toward the Th17 lineage. By using reporter mice
for Foxp3 and IL-17F, we found that the resulting cells express
Th17-specific genes and lack suppressive function. This action
by IL-6 is synergized by IL-1 and requires TGF-b. However, al-
though TGF-b, IL-6, IL-21, and IL-1 regulate the induction of
IL-17-producing cells, IL-6 seems most potent in downregulat-
ing Foxp3 expression. Terminally differentiated cells have been
shown to be able to dedifferentiate and redifferentiate. For ex-
ample, it was recently reported that mature B cells, when the
Pax5 gene was deleted, were able to redifferentiate into T cells
(Cobaleda et al., 2007). Interestingly, it was previously observed
that deletion of the Foxp3 gene in mature nTreg cells resulted in
loss of suppressive function and upregulation of IL-17 and IL-21
expression (Williams and Rudensky, 2007), suggesting that the
suppression of Th17 gene expression and the maintenance of
Treg programs both require Foxp3. Unlike these two cases,
here we observe the proinflammatory cytokine milieu in both
de- and redifferentiation of Treg cells. Our results are consistent
with recent work by Xu et al., who found that Treg cells convert
to Th17 cells when cultured with IL-6 in the absence of
TGF-b (Xu et al., 2007). These studies not only indicate the
plasticity of Th cell differentiation programs but also have impor-
tant implications. First, they suggest an alternative source of
Th17 cells in vivo, i.e., derived from Foxp3+ nTreg and iTreg cells.54 Immunity 29, 44–56, July 18, 2008 ª2008 Elsevier Inc.This pathway is potentially problematic because many Treg cells
have autoreactive specificities (Hsieh et al., 2004). Second, in fu-
ture therapy using Treg cells against autoimmune diseases, sup-
pression of inflammatory cytokines, especially IL-6, would be
needed simultaneously to prevent them from redifferentiating
into pathogenic Th17 cells.
How STAT3 mediates Foxp3 downregulation by IL-6 remains
to be determined. IL-6 induced Foxp3 mRNA downregulation
in nTreg cells 24 and 48 hr after treatment (data not shown). In
addition, we also found that in T cells transduced with Foxp3-ex-
pressing retroviruses, i.e., with exogenous promoters and un-
translated regions, IL-6 downregulated Foxp3 protein expres-
sion (data not shown). Regardless of which mechanism, this
important regulation will unleash the inhibitory function of
Foxp3, thus allowing Th17 cell differentiation to occur. It is of
note that although Foxp3 strongly inhibits Th17 cell differentia-
tion, substantial number of T cells coexpressed Foxp3 and
IL-17 and IL-17F in the early phase after IL-6 treatment. IL-17
and IL-17F expression was dependent on RORgt and RORa.
How RORa and RORgt overcome Foxp3 expression in these
cells remains to be understood. It is not clear at this stage
whether Foxp3 and IL-17 dual-expresser cells are bipotential.
In summary, we demonstrate in this study molecular mecha-
nisms of antagonistic regulation of Treg and Th17 programs,
both of which depend on TGF-b. In addition, our data indicate
the plasticity of nTreg and iTreg cells and the transcriptional
pathways that convert them to the Th17 program. These results
may be beneficial in our further understanding on the genetic
programs underlying Th cell differentiation and maintenance,
and have implications in immunotherapy. One may consider en-
hancing Treg generation and function in autoimmunity while con-
verting regulatory T cells to effector T cells in cancer patients.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, Rag1-deficient, and B6.SJL (CD45.1) mice were purchased from
Jackson Laboratories. Smad4fl/fl mice were kindly provided by M. Matzuk
with permission of E. Robertson (Chu et al., 2004), and these mice as well as
Stat3fl/fl mice were bred with CD4-Cre mice provided by C. Wilson. Scurfy
mice obtained from the Jackson Lab were crossed with OT-II mice, and
mice at 4 weeks of age were used. IL-21 knockout mice and Rorc/,
Rorasg/sg, and Rorasg/sgRorc/mice were described previously (Kurebayashi
et al., 2000; Nurieva et al., 2007; Yang et al., 2008b). Il17f rfp reporter was gen-
erated by insertion of an IRES-mRFP-polyA cassette into the exon 2 of the Il17f
gene (Yang et al., 2008a) and maintained on a 129xB6 F1 background. Mice
were housed in the specific pathogen-free (SPF) animal facility at M.D. Ander-
son Cancer Center, and the animal experiments were performed at the age of
6–10 weeks with protocols approved by Institutional Animal Care and Use
Committee.
T Cell Differentiation
CD4+CD25CD62LhiCD44lo cells were FACS sorted and stimulated and ana-
lyzed as described (Nurieva et al., 2007; Yang et al., 2007) All-trans retinoic
acid was purchased from Sigma and used at a 100 nM/ml concentration.
Gene expression was examined with a Bio-Rad iCycler Optical System with
the iQTM SYBR green real-time PCR kit (Bio-Rad Laboratories). The data
were normalized to Actb reference. The primers were previously described
(Nurieva et al., 2007; Yang et al., 2007).
MOG Immunization and Induction of EAE
Female mice at 5–8 weeks of age were immunized subcutaneously at the dor-
sal flanks with 150 mg of MOG35–55 peptide emulsified in CFA. Five days later,
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lated and restimulated with MOG for 24 hr, and RFP and GFP expression was
assessed by flow cytometry. Induction of EAE was as described (Yang et al.,
2008b).
Transcription-Reporter Assay
RORg, RORa, wild-type Foxp3, Foxp3DE250, Foxp3DFKH/NLS, Foxp3LL-AA,
Foxp3D105-190, or Foxp3LL-AA D105-190 were cloned into bicistronic retro-
viral vector pGFP-RV provided by K. Murphy that contains IRES-regulated
GFP. The expression vectors were transfected into EL-4 cells with a luciferase
construct containing IL-17 minimal promoter with CNS2 element (Yang et al.,
2008b). The dual-luciferase reporter system (Promega) was used to assay
Firefly and Renilla luciferase activity in each sample. Renilla luciferase was
used to normalize transfection efficiency and luciferase activity.
Two-Hybrid and RORE-Reporter Assay
CHO cells were cotransfected with 0.1 mg of a luciferase reporter, 0.05 mg of a
RORg-expressing vector, 0.1 mg of an LXXLL-motif-encoding vector
pM-EBIP96, and Foxp3-expressing vectors as indicated with Fugene 6 trans-
fection reagent (Roche, Indianapolis, IN). The luciferase reporter was (UAS)5-
Luc, containing five copies of the GAL4 upstream-activating sequence (UAS)
or (RORE)3-Luc, and the RORg-expressing vector is VP16-RORg or
pZeoSV-RORg. Cells were incubated for 40 hr, and then luciferase activity
was analyzed with a luciferase kit (Promega). Transfection efficiency was nor-
malized by b-galactosidase activity.
Coimmunoprecipitation
Expression vectors encoding RORa, wild-type, or mutant Foxp3 molecules
were transfected into 293 T cells. After 48 hr, cells were washed with
ice-cold PBS and lysed in ice-cold lysis buffer (50 mM Tris-HCl [pH 8.0],
120 mM NaCl, 1% Nonidet P-40, 4 mM EDTA, 50 mM NaF, 1 mM Na3VO4,
2 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin A). Lysates were ob-
tained by centrifugation and precleared with protein A-sepharose (Sigma-Al-
drich) for 2 hr before 2 mg of anti-FLAG-M2 antibody (Sigma-Aldrich) was
added. After incubation, protein A-Sepharose was added and immunoprecip-
itates were obtained by centrifugation. Equivalent amounts of protein from
whole-cell lysates or immunoprecipitates were analyzed by western blot using
anti-human and -mouse FOXP3 (eBioscience) or anti-FLAG-M2.
Retroviral Transduction
Naive CD4+CD25CD62LhiCD44lo T cells from OT-II mice were FACS sorted
and activated with Ova peptide and irradiated wild-type splenic APCs in the
presence of Th17 conditions (TGF-b, IL-6, IL-23, anti-IL-4, anti-IFN-g).
Twenty-four hours after activation, cells were infected by retroviruses express-
ing Foxp3 or control empty vector (containing only IRES-GFP) and analyzed
4 days later as previously described (Yang et al., 2008b).
In Vivo Conversion of Treg Cells
CD4+GFP+ cells from Foxp3-GFP reporter mice (CD45.2+) and
CD4+CD25CD62LhiCD44lo cells (CD45.1+) from B6.SJL congenic mice
were FACS sorted and mixed at 1:10 ratio. These cells were intravenously
transferred into syngenic Rag1/ mice (5 3 106 cells/mouse). The recipient
mice were immunized subcutaneously with 150 mg of MOG35-55 peptide emul-
sified in CFA. Five days later, lymphoid cells from spleens were isolated and
restimulated with MOG for 24 hr in the presence of Golgi-stop for last 5 hr or
PMA and Ionomycin and Golgi-stop for 5 hr. Cells were stained with PerCP-
Cy5.5-conjugated anti-CD45.2 together with APC-conjugated anti-CD4 be-
fore they were analyzed by intracellular staining.
SUPPLEMENTAL DATA
Supplemental Data include ten figures and can be found with this article online
at http://www.immunity.com/cgi/content/full/29/1/44/DC1/.
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